Imprimis NJOF, LLC: Drug Recall

Recall #D-0177-2021 · 12/17/2020

Class II: Risk

Recall Details

Recall Number
D-0177-2021
Classification
Class II
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Terminated
Date Initiated
12/17/2020
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6520 vials

Reason for Recall

Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.

Product Description

Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979

Distribution Pattern

U.S.A. Nationwide

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.